论文信息 - THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES - 字舞流文

THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES

J. Leeds | P. Hamlin | J. Curnutte | T. Fenske | J. Khatcheressian | C. Farber | D. Stevens | M. Schreeder | G. Coffey | M. Patel | J. Muñoz | C. Miller | M. Birrell | A. Pandey | S.M. Smith | Y. Wang